StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)

Close on Nov 17, 2026Market cap $1.24BP/E –Yield –

Avalyn Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Avalyn Pharma's total debt was $14.80M at Jun 30, 2026. For fiscal 2025 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.80M–
Q1 FY2026Mar 31, 2026$14.81M–
Q4 FY2025Dec 31, 2025$0–

More Avalyn Pharma figures

See a number that looks wrong?